Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular …

Most of the current guidelines and the existing data suggest that long‐term therapy with
nucleos (t) ide analogue (s)[NA (s)] may be stopped in carefully selected chronic hepatitis B …

Nucleos (t) ide analogs (NAs) are effective, safe, and convenient antiviral therapy to
suppress replication of hepatitis B virus, which can be translated into improved long‐term …